# The Blood Center – FDA Inspection, Feb 7, 2024

Source: https://www.keypedia.com/records/fda_inspections/the-blood-center/64d9115e-512f-42fb-80b1-c9a204cf7a67
Source feed: FDA_Inspections

> FDA inspection 1230714 of The Blood Center, February 07, 2024. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1230714
- Company Name: The Blood Center
- Inspection Date: 2024-02-07
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1105191 - 2019-09-10
- FDA Inspection 998088 - 2016-12-19
- FDA Inspection 923924 - 2015-04-21
- FDA Inspection 814617 - 2013-01-16
- [FDA Inspection 708140 - 2011-01-31](https://www.keypedia.com/records/fda_inspections/the-blood-center/04ae00ed-3777-481f-b61a-c4426f27dc49)

## Related Officers

- [FDA Personnel](https://www.keypedia.com/people/edward-a-brunt/f823f6cb-7fb1-422b-b022-cb0d673f6210)

Company: https://www.keypedia.com/companies/the-blood-center/349c3653-c078-45f9-918a-e6ca6a6eb7d5

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d